China retail slowdown dented Asian risk

U.S. benchmarks closed mixed: the Dow Jones Industrial Average (DJIA) rose 0.32%, the S&P 500 (SPX) slipped 0.07% and the Nasdaq Composite (^IXIC) fell 0.51% as sector moves and corporate headlines shaped intraday flows. European markets outperformed, with Germany's DAX (DAX) up 1.49%, the FTSE 100 (UKX) up 1.26% and France's CAC 40 (FRA40) up 0.44%. China's Shanghai Composite (000001.SS) was essentially flat as April retail sales slowed to 0.2% versus 1.7% previously and below consensus.

Sectors: Energy (XLE +1.92%), Financials (XLF +1.25%) and Consumer Defensive (XLP +1.49%) outperformed; Technology (VGT -1.04%) and Consumer Discretionary (XLY -0.18%) lagged. Notable gainers: RAMP (+27.71%), BRC (+13.95%), BIO (+11.32%), RBLX (+10.51%) and ZETA (+9.83%). Notable losers: AEHR (-14.88%), POET (-12.47%), USAR (-12.34%) and REGN (-10.44%).

China Retail Sales YoY slowed to 0.2% in April versus 1.7% previously and below consensus, weighing on Asian risk sentiment. China's Industrial Production YoY entries in the provided dataset lacked a definitive actual print for April, leaving industrial momentum unclear. Japan's preliminary Q1 GDP Growth Rate QoQ was scheduled with a consensus of 0.4% versus a prior 0.3%, but no actual value was provided in the dataset.

Baidu's Q1 results highlighted Core AI revenue up 49% and AI Cloud Infrastructure revenue up 79%, prompting premarket strength in U.S.-listed shares. Boston Scientific announced a $2.0 billion accelerated share repurchase with initial delivery of approximately 30.4 million shares and estimated ~$0.02 EPS accretion, and Cognizant raised its 2026 buyback target to $2.0 billion with a planned $1.0 billion revolver draw, reinforcing capital-allocation themes. S&P Dow Jones Indices implemented prior-to-open index changes (adding SharkNinja to the S&P MidCap 400 and moving Flowers Foods), creating mechanical rebalancing flows for SN, FLO and CSGS at the open. Several completed transactions closed on May 18, including Artivion's completion of its acquisition of Endospan Ltd., Neurocrine Biosciences' completion of its acquisition of Soleno Therapeutics, Zeeco's completion of its acquisition of Oil & Gas Technologies, and Tim Lamb Group's sale of seven Firelands Automotive Group dealerships. Announced deals included Qualtrics' $6.75 billion acquisition of Press Ganey Forsta and Critical Metals signing a definitive agreement to acquire European Lithium.